Skip to content
Medical Health Aged Care

Florey discovery could help reduce global shortage of diabetes and weight loss drug semaglutide

The Florey 2 mins read
Dr Chaitra Chandrashekar supplied by The Florey

Semaglutide is part of the glucagon-like peptide-1 (GLP-1) receptor targeting family of peptide drugs which are mainly used to treat diabetes but are difficult and expensive to make. 

An international team of researchers led by Professor Akhter Hossain at the Florey has developed a new faster and cheaper method to synthesize GLP-1 receptor targeting drugs. 

Professor Hossain, Head of The Florey’s Insulin Peptide Laboratory, said the discovery published today as the cover article of the Journal of Medicinal Chemistry could mean cost-effective and high-scale production in the future. 

“Semaglutide has proven to be more efficient than other anti-obesity drugs, in terms of weight loss and safety, and this has led to it being in short supply,” Professor Hossain said.  

“We set out to develop an improved and cost-efficient synthetic process for making a potential new drug to target the GLP-1 receptor. Semaglutide has a very ‘hydrophobic” component in its structure, meaning it’s not easily dissolved in water and thus challenging to manufacture.” 

The team used a chemical process called ‘glycosylation’, which differs to the ‘lipidation’ process used to make semaglutide, to make an analogue of GLP-1 that is ‘hydrophilic’ and much more easily dissolved. 

“Glycosylation resulted in ten-fold higher yields compared with semaglutide,” Professor Hossain said. 

Postdoctoral researcher in Professor Hossain’s laboratory, Dr Chaitra Chandrashekar, said it was exciting to be involved in research that could lead to benefit millions of people in the future. 

“Our short term experiments in animal models showed our potential drug performed as semaglutide would. It significantly lowered blood glucose levels and promoted enhanced glucose disposal,” Dr Chandrashekar said. 

“The method we’ve developed has fewer chemical steps and better yield than the current process for making semaglutide. Although more research is needed, it appears to be a way to rapidly and easily synthesize new drugs like semaglutide, while retaining their major therapeutic benefits for blood glucose control,” she said. 

Key Facts:

This study was funded by the NHMRC and an ARC Linkage Grant. Studies at The Florey were supported by the Victorian Government’s Operational Infrastructure Support Program. 

About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere. 

Find out more about us on our website: 

Contact details:

Kathryn Powley, Media and Communications Manager 


More from this category

  • Environment, Medical Health Aged Care
  • 12/04/2024
  • 14:56
Climate Media Centre

Government heat map ‘wake up call’ to stop burning fossil fuels

Friday 12 April 2024 Advocacy groups have welcomed the release of the Federal Government’s announcement of a heat mapping tool to assist affected communities deal with the worst of extreme heat, but have called on government to do more to address the root cause, climate change caused by the continued use of fossil fuels. Emma Bacon, Executive Director of Sweltering Cities “Heatwaves are Australia’s deadliest environmental disaster, so we welcome the Government’s acknowledgement of the severe impacts being felt by communities across the country. Clearly, some of the communities most impacted in areas like Western Sydney are facing climate, health,…

  • Biotechnology, Medical Health Aged Care
  • 12/04/2024
  • 13:40

UNSW and Mid North Coast Local Health District to boost research and students in rural communities

The strategic partnership will place UNSW students at local hospitals and streamline research collaboration opportunities. UNSW Sydney has signed an historic three-year Memorandum of…

  • Contains:
  • Medical Health Aged Care, Sport Recreation
  • 12/04/2024
  • 08:46
Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney

Industry backing for Wipeout Dementia raises $2.5 million for research

No amount of wild weather could stop Olympic Bronze Medalist Owen Wright and 1999 World Surfing Champion Mark Occhilupo from joining Sydney’s property industry…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.